Description

A focused course, tailored for you

The Non-Invasive Musculoskeletal Device Evidence Dossier

How a small Atlanta-style device team builds the regulatory, clinical, and quality dossier a hospital procurement office actually opens.

Your hand-held musculoskeletal instrument ships. Clinicians like it. The first hospital trial goes well. Then the procurement office asks for the regulatory classification, the clinical evidence, the quality system, and the cleaning protocol in one envelope, and the recurring purchase order stalls for four months while the team builds that envelope from scratch.

$199 one-time

Tailored to your situation. Access within 24 hours. 30-day money-back.

Includes a hand-built implementation playbook delivered alongside course access, generated for your specific situation.

Why this course

The technical lift of building a non-invasive soft-tissue or motion instrument is solvable. Mechanical engineers out of Georgia Tech and similar programs solve it routinely. The lift that stalls the business is the evidence binder a hospital system, a Division I athletics department, or a regional PT chain expects before the second order. That binder has a specific shape. It states the regulatory classification and cites the rule. It explains the predicate-device strategy or the rationale for why a clearance is not required. It carries a clinical evidence summary that a sports medicine physician will read in five minutes. It shows an ISO 13485 quality system position appropriate to the team size. It carries an ISO 14971 risk file that names the device-specific hazards. It carries a cleaning and reprocessing protocol the clinic can actually execute. It carries a clinician training package. It carries a complaint-handling workflow. Building that binder reactively, after a procurement request, costs four months of revenue. Building it as part of the product launch costs four weeks. This course is the four-week build.

What you walk away with

Place the device in the correct FDA classification with a written, citation-backed regulatory memo.
Build a predicate-device 510(k) strategy or a defensible non-device rationale that survives procurement review.
Ship a clinical evidence summary a sports medicine physician will read and sign off on in one sitting.
Stand up an ISO 13485 quality system scaled to a team under fifteen, with the documents auditors actually open.
Deliver a one-envelope procurement binder that converts a first trial into a recurring purchase order.

The 12 modules

Module 1. Classifying a non-invasive musculoskeletal instrument

Walks the FDA product classification database, the 21 CFR 890 musculoskeletal device part, and the wellness-versus-medical-device boundary. Ends with a written classification memo for your specific device naming the product code, the regulation number, the class, and the rationale. Covers when an instrument-assisted soft-tissue mobilization tool sits as a Class I exempt powered massager versus a Class II therapeutic device, and what intended-use language tips it between the two.

Module 2. Predicate-device strategy or non-device rationale

If the classification is Class II, walks how to find substantial-equivalence predicates in the 510(k) database, how to read the predicate's indications for use against yours, and how to build the predicate comparison table that anchors a 510(k) submission. If the classification is wellness, walks the FDA general wellness policy and the documentation that supports a non-device position. Output is either a predicate-match worksheet or a wellness-policy memo, with the citations a regulatory affairs consultant would expect to see.

Module 3. Indications for use, intended use, and labelling

Writes the indications-for-use statement that matches your classification and predicate strategy without overclaiming. Covers the difference between intended use and indications for use, where each lives in the dossier, and the labelling consequences of each word choice. Includes a labelling pack template, prescription-versus-over-the-counter decision, and the user manual structure that satisfies both FDA and clinician expectations.

Module 4. Clinical evidence without a full IRB trial

Builds the clinical evidence package for a low-risk non-invasive musculoskeletal device. Covers the published-literature search strategy, the bench testing that substitutes for clinical work in a 510(k), the post-market clinical follow-up plan, and the cases where a small prospective usability study at one Atlanta-area sports medicine clinic is appropriate. Ends with a clinical evidence summary document a sports physician or athletic trainer signs off in one read.

Module 5. ISO 13485 quality system at startup scale

Stands up the ISO 13485:2016 quality management system for a team under fifteen. Walks the required procedures, the document control approach that does not collapse under the team's actual workflow, the training records system, and the management review cadence. Includes a complete procedures pack scaled to startup reality, not Fortune 500 reality, and the gap-analysis worksheet that maps your current practice to each ISO 13485 clause.

Module 6. ISO 14971 risk management for a hand-held instrument

Builds the risk management file for a hand-held non-invasive instrument under ISO 14971:2019. Covers hazard identification specific to soft-tissue and motion devices, the harm-probability matrix appropriate to non-invasive contact, the risk-control hierarchy, and the residual risk acceptance. Ends with a complete risk file template including the device-specific hazard library so the team is not starting from a blank page.

Module 7. Cleaning, reprocessing, and biocompatibility position

Walks the FDA reprocessing guidance for reusable devices, the AAMI TIR12 framework, and the ISO 10993 biocompatibility evaluation. Builds a cleaning and reprocessing instruction set the clinic can actually execute between patients, with validation evidence appropriate to non-invasive skin contact. Output is the cleaning IFU, the biocompatibility evaluation memo, and the validation summary.

Module 8. Clinician training pack and competency evidence

Builds the clinician training package that ships with the device. Covers the technique manual, the competency checklist, the in-service training agenda for a sports medicine clinic or athletic training room, and the digital training assets that scale beyond in-person visits. Includes a measured-competency worksheet so procurement can see that clinicians are demonstrating, not just attending.

Module 9. Complaint handling, MDR reporting, and post-market surveillance

Stands up the complaint-handling workflow, the medical device reporting decision tree for 21 CFR 803, and the post-market surveillance plan. Walks how a small team can run this without a dedicated regulatory full-time hire, what gets logged where, and how the data feeds back into design changes. Output is the complaint procedure, the MDR decision worksheet, and the PMS report template.

Module 10. Procurement-side answers and the evidence binder

Assembles the one-envelope evidence binder a hospital or college athletics procurement office expects. Covers the order in which documents appear, the one-page executive summary that lives on top, the value analysis committee questions and the prepared answers, and the price-justification piece. Ends with the procurement binder fully assembled, ready to ship with the next quote.

Module 11. Selling into sports medicine, athletic training rooms, and outpatient rehab

Walks the buying centres in each of the three primary channels. Covers who signs at a Division I athletic department versus a hospital outpatient PT clinic versus a regional PT chain, the trial-to-recurring-order conversion path in each, and the contracting language each prefers. Ends with a channel-specific account plan and the trial-protocol template for each setting.

Module 12. The 90-day evidence-dossier build plan

Packages modules one through eleven into a 90-day build calendar tuned to your team size. Names the artefacts produced each week, the review checkpoints, and the external sign-offs the team will need to procure (a regulatory affairs reviewer, a clinical reviewer, an ISO 13485 lead auditor pre-assessment). Ends with the project plan, the artefact checklist, and the decision log template the team uses to keep the build honest.

How this addresses your situation

Specific modules that map to what you said you are dealing with.

First hospital or college athletics trial is going well and a recurring purchase order is the next milestone.

Procurement has asked for regulatory classification, clinical evidence, or ISO 13485 status and the answer is currently a forwarded email chain.

The team is preparing a seed or Series A round and an investor due-diligence question on regulatory pathway is imminent.

A clinician advisor has flagged that the current cleaning instructions or training package will not survive a hospital infection-control review.

What you get with this course

Twelve text modules in the Art of Service learning environment, each with downloadable templates and worked examples.
A hand-built implementation playbook tuned to the specific device class, intended-use language, and first-customer profile.
Worked-example regulatory classification memo, predicate comparison table, and indications-for-use statement.
Complete ISO 13485 procedures pack scaled to a team under fifteen, plus an ISO 14971 risk file template with a device-specific hazard library.
Cleaning and reprocessing IFU template, biocompatibility evaluation memo template, and clinician training and competency pack.
Procurement evidence-binder template, value analysis committee response prep, and a 90-day project plan.
30-day money-back position if the materials do not match the represented scope.

What you will have in hand by Day 1, Week 1, Month 1

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

Weeks one to four: classification memo, predicate strategy, indications for use, clinical evidence package.

Weeks five to eight: ISO 13485 quality system, ISO 14971 risk file, cleaning and reprocessing position.

Weeks nine to twelve: clinician training pack, complaint handling and MDR workflow, procurement binder assembled.

Before and after

Before

Trials convert at maybe one in four. Each conversion requires four months of binder assembly because procurement keeps asking for documents the team builds reactively. Clinical evidence is a marketing one-pager. ISO 13485 is on the roadmap for next quarter. The MDR decision tree is a question for a future regulatory hire.

After

Trials convert at well over half because the evidence binder ships with the device. Procurement opens it once, reads four key pages, and routes the recurring purchase order in the same week. Clinical evidence is a one-page summary a sports physician signs off in one read. ISO 13485 is operational at a startup-appropriate scale. The complaint-handling and MDR workflow is documented and the regulatory hire becomes a part-time consultant rather than a six-figure salary.

What happens if you do not address this

The longer the evidence binder is built reactively, one procurement request at a time, the longer the cash conversion cycle stays at four months and the more often a promising trial fails to convert to a recurring order. Each missed conversion is roughly one quarter of revenue. Six missed conversions is the runway difference between hiring an additional engineer and not. The build is the same work either way. Doing it once, upfront, costs four weeks. Doing it six times, reactively, costs six quarters of growth.

Who it is for

Engineering, product, or operations leads at small movement-instrument, manual-therapy-device, or sports-performance hardware companies. Teams of one to fifteen people. Often founders or early hires with strong engineering backgrounds and limited prior exposure to FDA regulatory pathways, ISO 13485, or hospital procurement processes. Selling into sports medicine clinics, athletic training rooms, physical therapy practices, or hospital outpatient rehab departments.

Who this is NOT for. This course is not for teams building implantable, electrically powered Class III devices, or any device requiring a PMA pathway. It is not for clinicians buying devices. It is not for general medical device consultants looking for a generic refresher. The clinical evidence module assumes a non-invasive musculoskeletal use case with low-risk profile.

How it arrives

Text-based course in the Art of Service learning environment, plus downloadable templates and worked examples for every module, plus the hand-built implementation playbook delivered alongside course access.

Time investment. Six to eight hours per week across twelve weeks for a single lead working through the material. Two to three hours per week per additional team member contributing to specific modules. Total team effort is roughly 100 to 140 hours to ship a complete evidence binder.

Why $199 is the right number

A boutique medical device regulatory consultant building the same dossier ranges from $40,000 to $120,000 over four to six months, with the team still doing most of the writing. A general medical device QMS template pack runs $2,000 to $8,000 but assumes the team already knows what to put in the templates. This course assumes the team can ship a device and need to learn what the binder looks like and why each piece is in it. The 199 dollar price is the on-ramp; the implementation playbook is the customisation a consultant would charge five figures to produce.

FAQ

Does this cover Class III implantable devices?

No. The course is built for non-invasive musculoskeletal instruments that route through Class I exempt, Class I, Class II 510(k), or the general wellness policy. Class III PMA pathways are out of scope.

Do I need an FDA regulatory consultant after this?

Most teams use a regulatory consultant for a pre-submission meeting and a final 510(k) review only, with the rest of the binder built in-house from the course materials. That moves the consultant spend from six figures to low five figures.

What if my device is software-only or has a software component?

The course assumes a physical instrument as the primary device. Software components such as a companion mobile app are covered in the labelling and risk modules at a high level, but a dedicated SaMD pathway is out of scope.

How is the implementation playbook tailored?

Within 24 hours of purchase, you send a short device profile (intended use, mechanism, first-customer segment, current dossier state). The playbook returns with the classification call already drafted, the predicate strategy already mapped, and the 90-day plan already sequenced for your specific device.

Can the materials be used as evidence in an actual FDA submission?

The templates are the working artefacts. Final submission documents need a regulatory affairs reviewer sign-off and your own device-specific data. The course teaches what the documents look like and why each piece is required; it does not substitute for a regulatory affairs reviewer on the submission itself.

30-day money-back guarantee. If after a week of working through the materials this is not what you needed, reply to the receipt email and a full refund is processed. No questions, no forms.

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.